Cargando…
Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?
The management of chronic hepatitis B virus (CHB) infection is an area of massive unmet clinical need worldwide. In spite of the development of powerful nucleoside/nucleotide analogue (NUC) drugs, and the widespread use of immune stimulators such as interferon-alpha (IFNα) or PEGylated interferon-al...
Autores principales: | Duraisamy, Ganesh Selvaraj, Bhosale, Dattatry, Lipenská, Ivana, Huvarova, Ivana, Růžek, Daniel, Windisch, Marc P., Miller, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552065/ https://www.ncbi.nlm.nih.gov/pubmed/32906840 http://dx.doi.org/10.3390/v12090998 |
Ejemplares similares
-
Precision medicine in COPD: where are we and where do we need to go?
por: Sidhaye, Venkataramana K., et al.
Publicado: (2018) -
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021) -
Research in Vascular Medicine: Where We Are and Where We Are Going
por: Qanadli, Salah D.
Publicado: (2020) -
Nuclear‐medicine probes: Where we are and where we are going
por: Gonzalez‐Montoro, Andrea, et al.
Publicado: (2022) -
AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)